1 Min Read
April 13 (Reuters) - Kuros Biosciences AG:
* Announces CEO succession
* Ivan Cohen-Tanugi has been appointed Chief Executive Officer with effect as of April 13, 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.